 |
Brandenburger
Tor |
|
Brandenburger
Tor |
Peer Reviewed Publications in International Journals (only English) 2000-2005
Publications list
2005
Böhler T, Budde K, Neumayer HH, Waiser J
Novel mediators of FTY720 in human lymphocytes
Transplantation: 79(4), 492-5, 2005
Budde K, Fritsche L
Proposal for guidelines for publication of randomized trials in the American Journal of Transplantation
Am J Transplant: 5, 644-7, 2005
Budde K, Fritsche L, Waiser J, Glander P, Slowinski T, Neumayer HH, RADW 102 Renal Transplant Study Group
Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patients
Eur J Med Res: 10, 169-74, 2005
Vítko S, Margreiter R, Weimar W, Dantal J, Kuypers D, Winkler M., Øyen O, Viljoen HG, Filiptsev P, Sadek S, Li Y, Cretin N, Budde K, RAD B201 Study Group
Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients.
Am J Transplant: 5(10), 2521-30, 2005
Nashan B, Bock A, Bosmans JL, Budde K, Fijter H, Jaques B, Johnston A, Lück R, Midtvedt K, Pallardó LM, Ready A, Salamé E, Salizzoni M, Suarez F, Thervet E
Use of Neoral C monitoring: a European consensus
Transplant Int: 18(7), 768-78, 2005
Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuño-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M
Corticosteroid-Free Immunosuppression with Tacrolimus, Mycophenolate Mofetil, and Daclizumab Induction in Renal Transplantation.
Transplantation: 79(7), 807-814, 2005
Budde K, Knoll G, Curtis J, Kahana L, Pohanka E, Seifu Y, Neumayer HH
Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.
Transplant P: 37(2), 912-5, 2005
Budde K, Lehne G, Winkler M, Renders L, Lison A, Fritsche L, Soulillou JP, Fauchald P., Neumayer HH, Dantal J
Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients
J Clin Pharmacol: 45(7), 781-91, 2005
Budde K, Salvadori M
Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF), it is Better to Have the Choice
Am J Transplant: 5(5) 1165-6, 2005
Diekmann F, Gutierrez-Dalmau A, Torregrosa JV, Oppenheimer F, Campistol JM
Sirolimus Monotherapy: Feasible Immunosuppression for Long-Term Follow-up of Kidney Transplantation-A Pilot Experience
Transplantation: 80(9), 1344-1348, 2005
W Arns, F Diekmann
Konsensus-Statement zu Umstellung und Therapieoptimierung nierentransplantierter Patienten mit Sirolimus - Update 2005
Nieren Hochdruck: Nieren- und Hochdruckkrankheiten, 34, Nr. 12/2005 551-555, 2005
Saurina A, Campistol JM, Piera C, Diekmann F, Campos B, Campos N, de Las Cuevas X, Oppenheimer F
Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria
Nephrol Dial Transpl: - -,2005
Ruiz JC, Diekmann F, Campistol JM, Sanchez-Fructuoso A, Rivera C, Oliver J,
Fernandez-Fresnedo G, Arias M
Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to Sirolimus (SRL) in renal transplant patients: a multicenter study
Transplant Proc: 37(9):3833-5, 2005
Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
New Engl J Med: 352(6), 558-69, 2005
Bräsen JH, Nieminen-Kelhä M, Markmann D, Malle E, Schneider W, Neumayer HH, Budde K, Luft FC, Dragun D
Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants
Kidney Int: 67(4), 1583-94, 2005
Einecke G, Melk A, Ramassar V, Zhu LF, Bleackley RC, Famulski KS, Halloran PF
Expression of CTL associated transcripts precedes the development of tubulitis in T-cell mediated kidney graft rejection
Am J Transplant: 5(8), 1827-36, 2005
Einecke G, Schütz M, Mai I, Fritsche L, Giessing M, Glander P, Neumayer HH, Budde K
Limitations of C2 monitoring in renal transplant recipients
Nephrol Dial Transpl: 20(7), 1463-70, 2005
Fleiner F, Budde K, Dragun D, Hartmann M, Neumayer HH, Fritsche L
Differences in reporting of acute rejections between American and European publications of large immunosuppressive trials impair comparability of study results
Transplant P: 37(5), 2048-50, 2005
Gaedeke J, Boehler T, Budde K, Neumayer HH, Peters H
Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis
Nephrol Dial Transpl: 20(2), 319-28, 2005
Gaedeke J, Peters H
Relaxin: exploring the antifibrotic potential of a pregnancy hormone
Kidney Int: 68(1), 405-6, 2005
Gaedeke J, Noble NA, Border WA
Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through
up-regulation of heme oxygenase 1.
Kidney Int.68(5): 2042-9, 2005
Haase M, Bellomo R, Rocktaeschel J, Ziemer S, Kiesewetter H, Morgera S, Neumayer HH
Use of fondaparinux (ARIXTRA(R)) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II
Nephrol Dial Transpl: 20(2), 444-6, 2005
Haase M, Morgera S, Bamberg C, Halle H, Martini S, Hocher B, Diekmann F, Dragun D, Peters H, Neumayer HH, Budde K
A systematic approach to managing pregnant dialysis patients--the importance of an intensified haemodiafiltration protocol
Nephrol Dial Transpl: 20(11), 2537-42, 2005
Hegner B, Weber M, Dragun D, Schulze-Lohoff E
Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells
J Hypertens: 23(6), 1191-202, 2005
Krämer S, Loof T, Martini S, Rückert M, Wang Y, Böhler T, Shimizu F, Kawachi H, Neumayer HH, Peters H
Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril
Am J Physiol-Renal: 289(2), F359-68, 2005
Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S
Renal blood flow in sepsis
Crit Care: 9(4), R363-74, 2005
Egi M, Naka T, Bellomo R, Cole L, French C, Trethewy C, Wan L, Langenberg CC, Fealy N, Baldwin I
A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration
Int J Artif Organs 28(12): 1211-8, 2005
Liefeldt L, Giessing M, Budde K, Neumayer HH
Contraindications to living donor kidney transplantation
Deut Med Wochenschr: 130(36), 2039-42, 2005
Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S
Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3
J Med Virol: 75(1) 161-9, 2005
Hein OV, Heymann v C, Morgera S, Konertz W, Ziemer S, Spies C
Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failure
Artif Organs: 29(6), 507-10, 2005
Morgera S, Haase M, Ruckert M, Krieg H, Kastrup M, Krausch D, Vargas-Hein O, Zuckermann-Becker H, Peters H, Pohlmeier R, Neumayer HH
Regional Citrate Anticoagulation in Continuous Hemodialysis - Acid-Base and Electrolyte Balance at an Increased Dose of Dialysis
Nephron Clin Pract: 101(4), c211-c219, 2005
Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Doig GS, Oudemans van Straaten H, Ronco C, Kellum JA, Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators
External validation of severity scoring systems for acute renal failure using a multinational database
Crit Care Med: 33(9), 1961-7, 2005
Uchino S, Kellum JA, Bellomo R., Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators
Acute renal failure in critically ill patients: a multinational, multicenter study
JAMA: 294(7), 813-8, 2005
Vargas Hein O, Staegemann M, Wagner D, Heymann v C, Martin M, Morgera S, Spies C
Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients
Renal Failure: 27(4), 385-92, 2005
Morgera S
Management of ARF with high permeability hemofiltration in sepsis: practical aspects. International Journal of Intensive Care. 8, 25-31, 2005
Fellström B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P., Olsson A.G., Staffler B., Pedersen T.R. & Assessment of Lescol in Renal Transplantation Study Investigators
Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial
Transplantation: 79(2), 205-12, 2005
Fellström B, Jardine AG, Soveri I, Cole E, Grönhagen-Riska C, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H, Assessment of Lescol in Renal Transplantation trial
Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial
Transplantation: 79(9), 1160-3, 2005
Fellström B, Jardine AG, Soveri I, Cole E, Neumayer HH, Maes B, Gimpelewicz C, Holdaas H, the ALERT Study Group
Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation
Am J Transplant: 5(8), 1986-91, 2005
Arns W, Zantvoort F, Abendroth D, Seiter H, Scheuermann EH, Albert U, Stahl R, Fornara P, Fricke L, Neumayer HH, Nagel E, Michel U, Ulbricht B
Cyclosporine C2 levels in de novo renal allograft recipients: a German multicenter prospective observational study
Transplant P: 37(3), 1612-5, 2005
Asmus HG, Braun J, Krause R, Brunkhorst R, Holzer H, Schulz W, Neumayer HH, Raggi P,
Bommer J
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
Nephrol Dial Transpl: 20, 1653-61, 2005
Fischer T, Neumayer HH, Fischer R, Barenbrock M, Schobel HP, Lattrell BC, Jacobs VR, Paepke S, von Steinburg SP, Schmalfeldt B, Schneider KT, Budde K
Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine
Am J Transplant: 5(11), 2732-9, 2005
Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study
Am J Transplant: 5(12), 2929-36, 2005
Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C, ALERT Study Group
Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation
Nephrol Dial Transpl: 20(5), 974-80, 2005
Jardine AG, Fellström B, Logan JO, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Pedersen T, Holdaas H
Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study
Am J Kidney Dis: 46(3), 529-36, 2005
Krämer BK, Neumayer HH, Stahl R, Pietrzyk M, Krüger B, Pfalzer B, Bourbigot B, Campbell S, Whelchel J, Eris J, Vitko S, Budde K, RADA2307 Study Group
Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of
cyclosporine, and basiliximab
Transplant P: 37(3), 1601-4, 2005
Neumayer HH
Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments
Transplantation: 79(9 Suppl), S72-5, 2005
Fritsche L, Hoerstrup J, Budde K, Reinke P, Neumayer HH, Frei U, Schlaefer A
Accurate prediction of kidney allograft outcome based on creatinine course in the first 6 months posttransplant
Transplant P: 37(2), 731-3, 2005
Skerjanec A, Tedesco H, Neumayer HH, Cole E., Budde K, Hsu CH, Schmouder R
FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship
J Clin Pharmacol: 45(11), 1268-78, 2005
Giessing M, Reuter S, Deger S, Tüllmann M, Hirte I. Budde K, Fritsche L, Slowinski T, Dragun D, Neumayer HH, Loening SA, Schönberger B
Laparoscopic versus open donor nephrectomy in Germany: impact on donor health-related quality of life and willingness to donate
Transplant P: 37(5), 2011-5, 2005
Naka T, Jones D, Baldwin I, Fealy N, Bates S, Goehl H, Morgera S, Neumayer HH, Bellomo R
Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report
Crit Care: 9(2), R90-5, 2005
Schmook T, Budde K, Ulrich C., Neumayer HH, Fritsche L, Stockfleth E
Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy
Nephrol Dial Transpl: 20(1), 220-2, 2005
Schuetz M, Einecke G, Mai I, Neumayer HH, Glander P, Waiser J, Fritsche L, Budde K
Problems of cyclosporine absorption profiling using C2-monitoring
Eur J Med Res: 10(4), 175-8, 2005
Pfab T, Chen YP, Slowinski T, Richter CM, Godes M, Arck PC, Halle H, Hocher B
Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy.
J Hypertens: 23(12), 2187-91, 2005
Wang Y, Krämer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H
Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis
Kidney Int: 68(1), 47-61, 2005
Wang Y, Kramer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H
Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation versus phosphodiesterase inhibition
Am J Physiol Renal Physiol, 290, Epub 2005 Jul 26.
2004
| Böhler T, Waiser J, Schütz M, Dragun D, Neumayer HH, Budde K FTY720 mediates apoptosis-independent lymphopenia in human renal allograft recipients: different effects on CD62L+ and CCR5+ T lymphocytes Transplantation: 77(9) 1424-32, 2004 Comment by Calne SR. FTY: not just a homely drug. Transplantation. 77(9):1327, 2004 |
|||
| Böhler T, Waiser J, Schuetz M, Neumayer HH, Budde K FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors Nephrol Dial Transpl: 19(3) 702-13, 2004 |
|||
| Pieper AK, Buhle F, Bauer S, Mai I, Budde K, Haffner D, Neumayer HH, Querfeld U The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation Nephrol Dial Transpl: 19(10) 2630-3, 2004 |
|||
| Budde K, Curtis J, Knoll G, Chan L, Neumayer HH, Seifu Y, Hall M, ERL B302 Study Group Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study Am J Transplant: 4(2) 237-43, 2004 |
|||
| Budde K, Glander P, Diekmann F, Dragun D, Waiser J, Fritsche L, Neumayer HH Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients Transplant P: 36(2 Suppl) 524S-527S, 2004 |
|||
| Budde K, Glander P, Diekmann F, Waiser J, Fritsche L, Dragun D, Neumayer HH Review of the immunosuppressant enteric-coated mycophenolate sodium Expert Opin Pharmacother: 5(6) 1333-45, 2004 |
|||
| Budde K, Neumayer HH., Lehne G, Winkler M, Hauser IA, Lison A, Fritsche L, Soulillou JP, Fauchald P, Dantal J Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients Nephrol Dial Transpl: 19(10) 2606-14, 2004 |
|||
Giessing M, Schonberger B, Fritsche L, Budde KEvaluation and follow-up of living kidney donorsDtsch Med Wochenschr. 23;129(4):147-50, 2004 |
|||
|
|||
| Mai I, Perloff ES, Bauer S, Goldammer M, Johne A, Filler G, Budde K, Roots I.MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients. Br J Clin Pharmacol.;58(5):548-53, 2004 |
|||
|
|||
|
|||
| Diekmann F, Fritsche L, Neumayer HH, Budde K Sirolimus dosage during and after conversion from calcineurin inhibitor therapy to sirolimus in chronic kidney transplant patients Kidney Blood Press R: 27(3) 186-90, 2004 |
|||
| Dragun D, Böhler T, Nieminen-Kelhä M, Waiser J, Schneider W, Haller H, Luft FC, Budde K, Neumayer HH FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury Kidney Int: 65(3) 1076-83, 2004 |
|||
| Dragun D, Fritsche L, Boehler T, Peters H, Budde K, Neumayer HH FTY720: early clinical experience Transplant P: 36(2 Suppl) 544S-548S, 2004 |
|||
| Einecke G, Mai I, Fritsche L, Slowinski T, Waiser J, Neumayer HH, Budde K The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression Nephrol Dial Transpl: 19(1) 215-22, 2004 |
|||
| Fritsche L, Budde K, Dragun D, Einecke G, Diekmann F, Neumayer HH Testosterone concentrations and sirolimus in male renal transplant patients Am J Transplant: 4(1) 130-1, 2004 |
|||
| Fritsche L, Dragun D, Neumayer HH, Budde K Impact of cyclosporine on the development of immunosuppressive therapy Transplant P: 36(2 Suppl) 130S-134S, 2004 |
|||
| Fritsche L, Einecke G, Fleiner F, Dragun D, Neumayer HH, Budde K Reports of large immunosuppression trials in kidney transplantation: room for improvement Am J Transplant: 4(5) 738-43, 2004 |
|||
|
|||
|
|||
|
|||
| Hocher B, Schwarz A, Slowinski T, Bachmann S, Pfeilschifter J, Neumayer HH, Bauer C In-vivo interaction of nitric oxide and endothelin J Hypertens: 22(1) 111-9, 2004 |
|||
| Hocher B, Ziebig R, Krause R, Asmus G, Neumayer HH, Liefeldt L, Stasch JP Relaxin is an independent risk factor predicting death in male patients with end-stage kidney disease Circulation: 109(19) 2266-8, 2004 |
|||
|
|||
|
|||
|
|||
|
|||
|
|||
|
|||
|
|||
|
|||
|
|||
| Liefeldt L, van Giersbergen PL, Dingemanse J, Rudolph B, Walde T, Budde K, Neumayer HH, Hocher B Treatment of secondary pulmonary hypertension with bosentan and its pharmacokinetic monitoring in ESRD Am J Kidney Dis (Ab '99): 43(5) 923-6, 2004 |
|||
| Morgera S, Scholle C, Melzer C, Slowinski T, Liefeld L, Baumann G, Peters H, Neumayer HH A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure Nephron Clin Pract: 98(1) c35-40, 2004 |
|||
| Morgera S, Scholle C, Voss G, Haase M, Vargas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience Nephron Clin Pract: 97(4) c131-6, 2004 |
|||
| Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Müller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status Am J Kidney Dis (Ab '99): 43(3) 444-53, 2004 |
|||
|
|||
|
|||
| Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study Am J Transplant: 4(6) 988-95, 2004 |
|||
| Lee WC, Uchino S, Fealy N, Baldwin I, Panagiotopoulos S, Goehl H, Morgera S, Neumayer HH, Bellomo R Super high flux hemodialysis at high dialysate flows: an ex vivo assessment. Int J Artif Organs: 27(1) 24-8, 2004 |
|||
| Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial Kidney Int: 66(4) 1549-55, 2004 |
|||
| Braun J, Asmus HG, Holzer H, Brunkhorst R, Krause R, Schulz W, Neumayer HH, Raggi P, Bommer J Long-term comparison of a calcium-free phosphate binder and calcium carbonate--phosphorus metabolism and cardiovascular calcification Clin Nephrol: 62(2) 104-15, 2004 |
|||
| Giessing M, Conrad S, Schönberger B, Huland H, Budde K, Neumayer HH, Loening SA Kidney donors and kidney transplantation in the elderly Urologe A: 43(8) 947-54, 2004 |
|||
| Giessing M, Reuter S, Schönberger B, Deger S, Tuerk I, Hirte I, Budde K, Fritsche L, Morgera S, Neumayer HH, Loening SA Quality of life of living kidney donors in Germany: a survey with the Validated Short Form-36 and Giessen Subjective Complaints List-24 questionnaires Transplantation: 78(6) 864-72, 2004 |
|||
| Hein OV, von Heymann C, Diehl T, Ziemer S, Ronco C, Morgera S, Siebert G, Kox WJ, Neumayer HH, Spies C Intermittent hirudin versus continuous heparin for anticoagulation in continuous renal replacement therapy Renal Failure: 26(3) 297-303, 2004 |
|||
|
|||
| Peters H, Eisenberg R, Daig U, Liefeldt L, Westenfeld R, Gaedeke J, Krämer S, Neumayer HH Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis Kidney Int: 65(6) 2238-48, 2004 |
|||
| Peters H, Martini S, Wang Y, Shimizu F, Kawachi H, Krämer S, Neumayer HH Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis Kidney Int: 66(4) 1434-43, 2004 |
|||
|
|||
| Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats J Hypertens: 22(1) 191-8, 2004 |
|||
|
|||
|
|||
| Slowinski T, Diehr P, Kleemann P, Fritsche L, Renders L, Budde K, Hauser IA, Neumayer HH, Hocher B No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients Nephrol Dial Transpl: 19 (11): 2846-51, 2004 |
|||
| Türck D, Weber W, Sigmund R, Budde K, Neumayer HH, Fritsche L, Rominger KL, Feifel U, Slowinski T Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment J Clin Pharmacol: 44(2) 163-72, 2004 |
|||
|
|||
|
2003
| Bauer S, Stormer E, Johne A, Kruger H, Budde K, Neumayer HH, Roots I & Mai I Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients Brit J Clin Pharmacol 55(2): 203-11 (2003) |
| Budde K, L Schmouder R, Nashan B, Brunkhorst R, W Lucker P, Mayer T, Brookman L, Nedelman J, Skerjanec A, Böhler T & Neumayer HH Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients Am J Transpl 3(7): 846-54 (2003) |
| Budde K, Neumayer HH, Fritsche L, Sulowicz W, Stompor T & Eckland D The pharmacokinetics of pioglitazone in patients with impaired renal function Brit J Clin Pharmacol 55(4): 368-74 (2003) |
| Giessing M & Budde K Sirolimus and lymphocele formation after kidney transplantation: an immunosuppressive medication as co-factor for a surgical problem? Nephrol Dial Transpl 18(2): 448-9 (2003) |
Giessing M, Slowinski T, Deger S, Tuerk I, Schonberger S, Budde K, Loening SA |
| Living donor Nephrectomy-No impact of genetic relationship Transplant Proc 35(8): 2860-2 (2003) |
| Mai I, Stormer E, Bauer S, Kruger H, Budde K & Roots I Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients Nephrol Dial Transpl 18(4): 819-22 (2003) |
| Giessing M, Slowinski T, Deger S, Tuerk I, Schonberger S, Budde K, Loening SA |
| 20-year experience with elderly donors in living renal transplantation. Transplant Proc 35(8): 2855-7 (2003) |
| Giessing M, Budde K, Fritsche L, Slowinski T, Tuerk I, Schoenberger B, Neumayer HH, Loening SA |
| "Old-for-old" cadaveric renal transplantation: surgical findings, perioperative complications and outcome. Eur Urol 44(6): 701-8 (2003) |
| Mai I, Stormer E, Goldammer M, Johne A, Kruger H, Budde K, Roots I |
MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients J Clin Pharmacol 43(10): 1101-7 (2003) |
| Giessing M, Kroencke TJ, Taupitz M, Feldmann C, Deger S, Turk I, Budde K, Ebeling V, Schoenberger B, Loening SA |
| Gadolinium-enhanced three-dimensional magnetic resonance angiography versus conventional digital subtraction angiography which modality is superior in evaluating living kidney donors? Transplantation 76(6): 1000-2 (2003) |
| Nashan B, Armstrong VW, Budde K, Fricke L, Heemann U, Lück R, Röthele E, Scheuermann EH, Suwelack B |
| Cyclosporine C2-monitoring for optimisation of immunosuppression in renal transplantation – recommendations according to first experiences in german centers Transplantationsmedizin 15: 15-24 (2003) |
| Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F Inhibition of erythrocyte cation channels by erythropoietin |
| J Am Soc Nephrol 14(11): 2750-7 (2003) |
| Lang F, Lang KS, Wieder T, Myssina S, Birka C, Lang PA, Kaiser S, Kempe D, Duranton C, Huber SM Cation channels, cell volume and the death of an erythrocyte |
| Pflugers Arch 447(2): 121-5 (2003) |
| Bohler T, Waiser J, Schutz M, Schumann B, Neumayer HH, Budde K. |
| Pharmacodynamics of FTY720, the first member of a new class of immune-modulating therapeutics in transplantation medicine. Int J Clin Pharmacol Ther 41(10): 482-7 (2003) |
| Dragun D, Brasen JH, Schonemann C, Fritsche L, Budde K, Neumayer HH, Luft FC, Wallukat G |
| Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor Transplant Proc 35(6): 2104-5 (2003) |
| Dell K, Bohler T, Gaedeke J, Budde K, Neumayer HH & Waiser J Impact of PGE1 on cyclosporine A induced up-regulation of TGF-beta1, its receptors, and related matrix production in cultured mesangial cells Cytokine 22(6): 189-93 (2003) |
| Einecke G, Mai I, Fritsche L, Slowinski T, Waiser J, Glander P, Bohler T, Neumayer HH, Budde K. |
| Cyclosporin C2hour monitoring after renal transplantation. Int J Clin Pharmacol Ther 41(10): 477-81 (2003) |
| Salvadori M, Rosati A, Bock A, Chapman J, Dussol B, Fritsche L, Jeffery J, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, Tufveson G |
| One-year posttransplant renal function is a strong predictor of long-term kidney function: results from the Neoral-MOST observational study Transplant Proc 35(8): 2863-7 (2003) |
| Fritsche L, Budde K & Neumayer HH [Treatment of hypercholesterolemia in kidney transplant recipients] Deut Med Wochenschr 128(16): 879-81 (2003) |
| Fritsche L, Budde K & Neumayer HH Evaluating candidates for kidney transplantation: some recommendations still lack convincing clinical evidence Nephrol Dial Transpl 18(3): 621-2 (2003) |
| Fritsche L, Budde K, Glander P, Einecke G, Diekmann F, Schotschel R, Neumayer HH |
| Treating type 2 diabetes in renal insufficiency: the role of pioglitazone Int J Clin Pharmacol Ther 41(10): 488-91 (2003) |
| Fritsche L, Horstrup J, Budde K, Reinke P, Giessing M, Tullius S, Loening S, Neuhaus P, Neumayer HH, Frei U |
| Old-for-old kidney allocation allows successful expansion of the donor and recipient pool Am J Transplant 3(11): 1434-9 (2003) |
| Fritsche L; Hoerstrup J, Budde K, Frei U, Kahl A, Loening S, May G, Neuhaus P, Neumayer HH, Reinke P, Schoenberger B, Schoenemann C |
| Kidney transplantation at the Charité, elderly patients and the duration of hospitalization Clinical Transplants 171-179 (2003) |
| Glander P, Hambach P, Braun KP, Fritsche L, Waiser J, Mai I, Neumayer HH, Budde K |
| Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients Int J Clin Pharmacol Ther 41(10): 470-6 (2003) |
| Thone-Reineke C, Olivier J, Godes M, Zart R, George I, Bauer C, Neumayer HH & Hocher B Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension Clin Sci 104(1): 79-85 (2003) |
| Hocher B, Kalk P, Slowinski T, Godes M, Mach A, Herzfeld S, Wiesner D, Arck PC, Neumayer HH & Nafz B ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease J Am Soc Nephrol 14(2): 367-76 (2003) |
| Hocher B, Ziebig R, Altermann C, Krause R, Asmus G, Richter CM, Slowinski T, Sinha P & Neumayer HH Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis J Am Soc Nephrol 14(9): 2329-37 (2003) |
| Wagner FD, Buz S, Knosalla C, Hetzer R, Hocher B |
| Modulation of circulating endothelin-1 and big endothelin by nitric oxide inhalation following left ventricular assist device implantation Circulation 108 Suppl 1: II278-84 (2003) |
| Quaschning T, Kocak S, Bauer C, Neumayer HH, Galle J & Hocher B Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice Nephrol Dial Transpl 18(3): 479-83 (2003) |
| Quaschning T, Ruschitzka F, Stallmach T, Shaw S, Morawietz H, Goettsch W, Hermann M, Slowinski T, Theuring F, Hocher B, Luscher TF, Gassmann M |
| Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice FASEB J 17(2): 259-61 (2003) |
| Liefeldt L, Destanis P, Rupp K, Morgera S & Neumayer HH The hazards of whirlpooling Lancet: 361(9356): 534 (2003) |
| Anders HJ, Banas B, Linde Y, Weller L, Cohen CD, Kretzler M, Martin S, Vielhauer V, Schlondorff D, Grone HJ |
| Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors J Am Soc Nephrol 14(2): 317-26 (2003) |
| Anders HJ, Frink M, Linde Y, Banas B, Wornle M, Cohen CD, Vielhauer V, Nelson PJ, Grone HJ, Schlondorff D. |
| CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 170(11): 5658-66 (2003) |
| Steffgen J, Kampfer K, Grupp C, Langenberg C, Muller GA, Grunewald RW |
| Osmoregulation of aldose reductase and sorbitol dehydrogenase in cultivated interstitial cells of rat renal inner medulla Nephrol Dial Transplant 18(11): 2255-61 (2003) |
| Morgera S, Haase M, Rocktaschel J, Bohler T, Vargas-Hein O, Melzer C, Krausch D, Kox WJ. Baumann G, Beck W, Gohl H & Neumayer HH Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure Nephron Clin Pract 94(3): C75-80 (2003) |
| Morgera S, Klonower D, Rocktaschel J, Haase M, Priem F, Ziemer S, Wegner B, Gohl H & Neumayer HH TNF-alpha elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? Nephrol Dial Transpl 18(7): 1361-9., (2003) |
| Morgera S, Rocktaschel J, Haase M, Lehmann C, Von Heymann C, Ziemer S, Priem F, Hocher B, Gohl H, Kox WJ, Buder HW & Neumayer HH Intermittent high permeability hemofiltration in septic patients with acute renal failure Intens Care Med: (2003) |
| Morgera S, Haase M, Rocktaschel J, Bohler T, von Heymann C, Vargas-Hein O, Krausch D, Zuckermann-Becker H, Muller JM, Kox WJ, Neumayer HH |
| High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure Nephrol Dial Transplant 18(12): 2570-6 (2003) |
| Lee WC, Uchino S, Fealy N, Baldwin I, Panagiotopoulos S, Goehl H, Morgera S, Neumayer HH, Bellomo R |
| Beta2-microglobulin clearance with super high flux hemodialysis: an ex vivo study Int J Artif Organs 26(8): 723-7 (2003) |
| Morgera S, Schlenstedt J, Hambach P, Giessing M, Deger S, Hocher B, Neumayer HH |
| Combined ETA/ETB receptor blockade of human peritoneal mesothelial cells inhibits collagen I RNA synthesis. Kidney Int 64(6): 2033-40 (2003) |
| Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Solbu DO & Pedersen TR Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361(9374): 2024-31 (2003) |
| Peters H, Border WA, Rückert M, Krämer S, Neumayer HH & Noble NA l-Arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis Kidney Int 63(4): 1382-92 (2003) |
| Peters H, Daig U, Martini S, Rückert M, Schaper F, Liefeldt L, Krämer S & Neumayer HH NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis Kidney Int 64(2): 509-18 (2003) |
| Peters H, Martini S, Woydt R, Rückert M, Shimizu F, Kawachi H, Liefeldt L, Krämer S & Neumayer HH Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis Am J Physiol Renal 284(5): F1105-14 (2003) |
| Peters H, Rückert M, Gaedeke J, Liefeldt L, Ketteler M., Sharma A.M. & Neumayer HH Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis J Hypertens 21(4): 771-80 (2003) |
| Dimmler A, Haas CS, Cho S, Hattler M, Forster C, Peters H, Schocklmann HO, Amann K |
| Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-thy 1.1 and murine habu snake venom glomerulonephritis Diagn Mol Pathol 12:108-17 (2003) |
| Schmid H, Henger A, Cohen CD, Frach K, Grone HJ, Schlondorff D, Kretzler M for the |
| Members of the European Renal cDNA Consortium (ERCB, hier: Peters H, Neumayer HH) Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases J Am Soc Nephrol 14: 2958-2966 (2003) |
| Eitner F, Ostendorf T, Kretzler M, Cohen CD, Eriksson U, Grone HJ, Floege J & the Members of the European Renal cDNA Consortium (ERCB, hier: Peters H, Neumayer HH) |
| PDGF-C expression in the developin and normal adult human kidney and in glomerular diseases J Am Soc Nephrol 14: 1145-1153 (2003) |
| Pfab T, Stoltenburg-Didinger G, Trautner C, Godes M, Bauer C, Hocher B |
| The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivo Br J Pharmacol [Epub ahead of print] (2003) |
| Rothermund L, Kossmehl P, Neumayer HH, Paul M, Kreutz R |
| Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension J Hypertens 21(12): 2389-97 (2003) |
| Waiser J, Böhler T, Stoll J, Schumann B, Budde K, Neumayer HH |
| The immunosuppressive potential of misoprostol – efficacy and variability. Clin Immunol 109: 288-294 (2003) |
2002
Boehler T, Schütz M, Budde K, Neumayer HH, Waiser J
FTY720 alters the composition of T-lymphocyte subpopulations in the peripheral blood compartment of renal transplant patients
Transplant Proc 34: 2242 (2002)
Braun KP, Glander P, Hambach P, Böhler T, Waiser J, Mai I, Neumayer HH, Budde K
Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil Under Oral and Intravenous Therapy
Transplant Proc 34: 1745 - 1747 (2002)
Budde K, Smettan S, Fritsche L, Waiser J, Neumayer HH
Five Year Outcome of Tacrolimus Rescue Therapy in Late Rejection After Renal Transplantation
Transplant Proc 34:1594 – 1596 (2002)
Budde K, Hallebach G, Geißler S, Fritsche L, Diekmann F, Waiser J, Neumayer HH
Successful Steroid Withdrawal at the End of the 1st Year After Renal Transplantation in Mycophenolate Mofetil-Treated Patients
Transplant Proc 34:1700 - 1702 (2002)
Budde K, Geissler S, Hallebach G, Waiser J, Fritsche L, Böhler T, Neumayer HH
Prospective Randomized Pilot Study of Steroid Withdrawal With Mycophenolate Mofetil in Long-Term Cyclosporine-Treated Patients: 4-year Follow-Up
Transplant Proc 34: 1703 - 1705 (2002)
Budde K, Braun KP, Glander P, Böhler T, Hambach P, Fritsche L, Waiser J, Mai I, Neumayer HH
Pharmacodynamic Monitoring of Mycophenolate Mofetil in Stable Renal Allograft Recipients
Transplant Proc 34: 1748 - 1750 (2002)
Budde K, Schmouder RL, Brunkhorst R, Nashan B, Lucker PW, Mayer T, Choudhury S, Skerjanec A, Kraus G, Neumayer HH
First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients
J Am Soc Nephrol 13: 1073 – 1083 (2002)
Giessing M, Fischer TJ, Deger S, Türk I, Schönberger B, Fritsche L, Neumayer HH, Loening SA, Budde K
Increased Frequency of Lymphoceles Under Treatment With Sirolimus Following Renal Transplantation: A Single Center Experience
Transplant Proc 34: 1815 - 1816 (2002)
Giessing M, Deger S, Türk I, Schönberger B, Budde K, Loening SA
Laparoscopic donor nephrectomy in Germany
Transplant Proc 34: 3099 – 3101 (2002)
Schönberger B, Giessing M, Vogler H, Budde K, Loening S
Relevance and meaning of prostate cancer in kidney transplantation
Transplant Proc 34: 2225 – 2226 (2002)
Preikschat P, Gunther S, Reinhold S, Will H, Budde K, Neumayer HH, Krüger DH, Meisel H
Complex HBV populations with mutations in vore promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients
Hepatology 35: 466 – 477 (2002)
Einecke G, Mai I, Diekmann F, Fritsche L, Neumayer HH, Budde K
Cyclosporine Absorption Profiling and Therapeutic Drug Monitoring Using C2 Blood Levels in Stable Renal Allograft Recipients
Transplant Proc 34: 1738 - 1739 (2002)
Fritsche L
Ist der EbM-Kenntnisstand messbar?
Z Ärztl. Fortbild Qualitätssich 96: 58 (2002)
Fritsche L, Schläfer A, Budde K, Schröter K, Neumayer HH
Recognition of critical situations from time series of laboratory results by case-based reasoning
J Am Med Inform Assn 9: 520 – 528 (2002)
Fritsche L, Greenhalgh T, Falck-Ytter Y, Neumayer HH, Kunz R
Do short vourses in evidence based medicine improve knowledge and skills? Validation of Berlin questionnaire and before and after study of courses in evidence based medicine
BMJ 325: 1335 – 1341 (2002)
Hocher B, Godes M, Olivier J, Weil J, Eschenhagen T, Slowinski T, Neumayer HH, Bauer C, Paul M, Pinto YM
Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension
J Hypertens 20: 745 – 751 (2002)
Hocher B, Pleschka A, Yang F, Kraus R, Neumayer HH, Filler G
G protein Beta3 subunit 825T genotype is not associated with differing outcome in pediatric renal transplant recipients
Pediatr Transplant 6: 141 – 146 (2002)
Hocher B, Slowinski T, Hauser I, Vetter B, Fritsche L, Bachert D, Kulozik A, Neumayer HH
Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients
Thromb Hämostasis 87: 194 – 198 (2002)
Hocher B, Ehrenreich H
ETB receptor deficiency causes salt-sensitive hypertension
J Mol Med 80: 747 – 749 (2002)
Filler G, Hocher B
The emerging role of gene polymorphisms deterining outcome after solid-organ transplantation
Pediatr Transpl 6: 12 – 14 (2002)
Trenkner J, Priem F, Bauer C, Neumayer HH, Raschak M, Hocher B
Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner
Clin Sci 103: 385 – 388 (2002)
Schwarz A, Godes M, Thone-Reineke C, Theuring F, Bauer C, Neumayer HH, Hocher B
Tissue-dependent expression of matrix proteins in human endothelin-1 transgenic mice
Clin Sci 103: 39 – 43 (2002)
Kunz R, Neumayer HH, Khan KS
When small degrees of bias in randomized trials can mislead clinical decisions: an example of individualizing preventive treatment of upper gastrointestinal bleeding
Crit Care Med 30: 1503 – 1507 (2002)
Liefeldt L, Buhl M, Schweickert B, Engelmann E, Sezer O, Laschinski P, Preuschof L, Neumayer HH
Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy.
Nephrol Dial Transpl 17: 1840 – 1842 (2002)
Morgera S, Kraft AK, Siebert G, Luft FC, Neumayer HH
Long-term outcomes in acute renal failure patients treated with continuous renal replacement
therapies
Am J Kidney Dis 40: 275 – 279 (2002)
Morgera S, Woydt R, Kern H, Schmutzler M, DeJonge K, Lun A, Rohde W, Konertz W, Kox WJ, Neumayer HH
Low-dose prostacyclin prstacyclin preserves renal function in high-risk patients after coronary bypass surgery
Crit Care Med 30: 107 – 112 (2002)
Uchino S, Bellomo R, Morimatsu H, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P, Morgera S, Neumayer HH, Göhl H
Cytokine dialysis: an ex vivo study
Asaio J 48: 650 – 653 (2002)
Schachschal G, Morgera S, Kupferling S, Neumayer HH, Lochs H, Schmidt HJ
Emerging indications for MARS® dialysis
Liver 22: 63 – 68 (2002)
Kovarik JM, Hartmann S, Figueiredo J, Rordorf C, Golor G, Lison A, Budde K, Neumayer HH
Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants
Pharmacotherapy 22: 154 – 159 (2002)
2001
Böhler
T, Budde K, Schneider M, Eliazyfer S, Dell K, Einecke G, Diekmann F, Fritsche
L, Mai I, Neumayer HH, Waiser J
Pharmacodynamic monitoring of lymphocyte proliferation and TGF-1 expression
at cyclosporine a (CyA) trough levels (C0) and 2 hours after intake (C2) of
CyA in human renal allograft recipients
Transplant P 33: 3148 - 3150 (2001)
Böhler
T, Budde K, Schneider M, Elijazyfer S, Dell K Neumayer HH, Waiser J
Pharmakodynamisches Monitoring von Cyclosporin-A-behandelten, nierentransplantierten
Patienten – Lymphozytenproliferation und TGF-ß1 als Parameter
zur Evaluierung optimierter C2-Medikamentenspiegel
Dialyse Aktuell 8: 18 – 20 (2001)
Budde
K, Fritsche L, Geißler S, Hallebach G, Diekmann F, Mai I, Böhler
T, Waiser J, Neumayer HH
Steroid withdrawal in long-term cyclosporine a treated patients using mycophenolate
mofetil: a prospective randomized pilot study
Transplant P 33: 3250 - 3252 (2001)
Budde
K, Glander P, Braun KP, Böhler T, Waiser J, Fritsche L, Mai I, Neumayer
HH
Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients
Transplant P 33: 3313 - 3315 (2001)
Giessing
M, Türk I, Deger S, Schönberger B, Budde K, Loening SA
Laparoscopic kidney harvesting for living donor kidney transplantation - one
year follow-up of the initial 15 patients
Transplant P 33: 3791 - 3792 (2001)
Dell
K, Böhler T, Gaedeke J, Budde K, Neumayer HH, Waiser J
Prostaglandin E1 inhibits cyclosporine A-induced upregulation of transforming
growth factor-beta 1 in rat mesangial cells
Transplant P 33: 3342 - 3344 (2001)
Diekmann
F, Rudolph B, Plauth M, Morgera S, Slowinski T, Priem F, Neumayer HH, Hocher
B
Hypookalemic nephropathy after pelvic pouch procedure and protective loop
Ileostomy
Z Gastroenterol 39: 579 - 582 (2001)
Diekmann F, Waiser J, Fritsche L, Dragun D, Neumayer HH, Budde K
Conversion to rapamycine in renal allograft recipients with biopsy-proven
calcineurin inhibitor-induced nephrotoxicity.
Transplant P 33: 3234 – 3235 (2001)
Dragun
D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, Haller H
Prolonged cold preservation augments vascular injury independent of renal
transplant immunogenicity and function
Kidney Int 60: 1173 – 1181 (2001)
Einecke
G, Mai I, Diekmann F, Fritsche L, Boehler T, Neumayer HH, Budde K
Optimizing neoral therapeutic drug monitoring with cyclosporine trough (C0)
and C2 concentrations in stable renal allograft recipients.
Transplant P 33: 3102 – 3103 (2001)
Fritsche
L, Lohmann R, Langrehr JM, Neuhaus P, Neumayer HH
Damit das Honorarsystem nicht zum Glücksspiel wird: Die rückwirkende
DRG-Eingruppierung erfordert die Dokumentation des Wegs zur „Hauptdiagnose“
f&w 18: 173 – 175 (2001)
Fritsche
L, Schlaefer A, Budde K, Schroeter K, Neumayer HH
Case-based reasoning algorithm for kidney transplant monitoring.
Transplant P 33: 3331 – 3333 (2001)
Fritsche
L, Donner-Banzhoff N, Druck G, Kunz R, Langenberg C, Lelgemann M. Pientka
L, von Maxen A, Wehner M, Neumayer HH
EbM-Kurse für Klinik und Praxis – die aktuellen Modelle in Deutschland
ZaeFQ 95: 297 – 317 (2001)
Kröncke
TJ, Taupitz M, Anrold R, Fritsche L, Hamm B
Three-Dimensional Gadolinium-Enhanced Magnetic Resonance Venography in Suspected
Thromboocclusive Disease of the Central Chest Veins
Chest 120: 1570 – 1576 (2001)
Glander
P, Braun KP, Hambach P, Bauer S, Mai I, Roots I, Waiser J, Fritsche L, Neumayer
HH, Budde K.
Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH)
in peripheral mononuclear cells.
Clin Biochem 34: 543 - 549 (2001)
Hocher B, Slowinski T, Bauer C, Halle H
The advanced fetal programming hypothesis
Nephrol Dial Transpl 16: 1298 - 1299 (2001)
Riemekasten
G, Kawald A, Marell J, Weiß C, Klein R, Hocher B, Meisel C, Hausdorf
G, Kamradt T, Burmester G, Hiepe F
Development of anti-dsDNA antibodies, rapid renal failure and death in lupus
prone mice by injection of the C-terminal SmD1 peptide 83-119
Arthritis Rheum 44: 2435 - 2445 (2001)
Hocher
B, Dembowski C, Slowinski T, Friese ST, Thöne-Reineke C, Schwarz A, Siren
AL, Neumayer HH, Nafz B, Ehrenreich H
Impaired Sodium Excretion, Decreased Glomerular Filtration Rate and Elevated
Blood Pressure in ETB-Receptor Deficient Rats
J Mol Med Jmm 78: 633 - 641 (2001)
Boemke
W, Hocher B, Krebs MO, Schleyer N, Kaczmarczyk G
Hemodynamic, renal and endocrine responses to acute ET(A) blockade at different
ANG II plasma levels
Am J Physiol Reg I 280: 1322 - 1331 (2001)
Patzak
A, Mrowka R, Storch E, Hocher B, Persson PB
Interaction of Angiotensin II and Nitric Oxide in Isolated Perfused Afferent
Arterioles of Mice
J Am Soc Nephrol 12:1122 - 1127 (2001)
Hocher
B, Schwarz A, Reinbacher D, Jacobi J, Lun A, Priem F, Neumayer HH, Raschack
M
Effects of Endothelin Receptor Antagonists on the Progression of Diabetic
Nephropathy. Nephron 87: 161 - 169 (2001)
Fischereder
M, Luckow M, Hocher B, Wüthrich RP, Rothenpieler U, Schneeberger H, Panzer
U, Stahl R, Hauser IA, Budde K, Neumayer HH, Krämer BK, Land W, Schlöndorff
D
CC chemokine receptor 5 and renal-transplant survival
Lancet 357: 1758 - 1761 (2001)
Filler
G, Yang F, Martin A, Stolpe J, Neumayer HH, Hocher B
Renin Angiotensin System Gene Polymorphisms in Paediatric Renal Transplant
Recipients
Paediatr Transplant 5: 166 - 173 (2001)
Kunz
R, Fritsche L, Neumayer HH
Entwicklung eines Gegenstandskatalog als Basis einer reproduzierbaren Ausbildungsqualität
in evidenzbasierter Medizin
ZaeFQ 95: 371 – 375 (2001)
Donner-Banzhoff
N, Kunz R, Rosser W
Studies of symptoms in primary care
Fam Pract 18: 33 – 38 (2001)
Schmidt-Ott
KM, XuAD, Tuschick S, Liefeldt L, Kresse W, Verkhratsky A, Kettenmann H, Paul
M
Hypoxia reverses dibutyryl-cAMP-induced stellation of cultured astrocytesvia
activation of the endothelin system
Faseb J 15: 1227 – 1229 (2001)
Vargas
HO, Heymann v C, Lipps M, Ziemer S, Ronco C, Neumayer HH, Morgera S, Welte
M, Kox WJ, Spies C
Hirudin versus heparin for anticoagulation in continuous renal replacement
therapy
Intens Care Med 27: 673 – 679 (2001)
Holdaas
H, Fellström B, Holme I, Nyberg G, Fauchald P, Jardine A, Grönhagen-Riska
C, Madsen S, Neumayer HH, Cole E, Maes B
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT
(Assessment of Lescol in Renal Transplantation) study design and baseline
data
J Cardiovasc Risk 8: 63 – 71 (2001)
Rothermund
L, Pinto YM, Vetter R, Herfort N, Kossmehl P, Neumayer HH, Paul M, Kreutz
R
Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis
and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing
the Ren2 gene
J Hypertens 19: 1465 – 1472 (2001)
Tullius
SG, Reutzel-Selke A, Bachmann U, Jurisch A, Nieminen-Kelhä M, Pratschke
J, Jonas S, Steinmüller T, Volk HD, Neuhaus P
Influence of recipient and donor age on long-term renal allograft function
in an experimental model
Transplant P 33: 3345 - 3346 (2001)
Tullius SG, Reutzel-Selke A, Nieminen-Kelhä M, Jonas S, Pratschke J,
Bachstein WO, Neuhaus P, Volk H
Tolerance induction by the graft itself
Transplant P 33: 2317 – 2318 (2001)
Tullius
SG, Nieminen-Kelhä M, Bachmann U, Reutzel-Selke A, Jonas S, Pratschke
J, Bachstein WO, Reinke P, Bülow R, Neuhaus P, Volk H
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves
long-term graft outcome in rat renal allografts
Transplant P 33: 1286 – 1287 (2001)
Tullius
SG, Nieminen-Kelhä M, Reutzel-Selke A, Bachmann U, Jonas S, Pratschke
J, Bachstein WO, Volk H, Bülow R, Neuhaus P, Reinke P
Improvement of long-term function in renal allografts from ´marginal
donors´ following the induction of heme-oxygenase-1
Transplant P 33: 1160 – 1161 (2001)
Reutzel-Selke
A, Tullius SG, Zschockelt T, Nieminen-Kelhä M, Bachmann U, Jonas S, Pratschke
J, Schmidbauer G, Bechstein WO, Volk H, Neuhaus P
Donor pretreatment of grafts from marginal donors improves long-term graft
outcome
Transplant P 33: 970 – 971 (2001)
Gaedeke
J, Peters H, Noble NA, Border WA
Angiotensin II, TGF-ß and renal fibrosis
Contrib Nephrol 135: 153 – 160 (2001)
2000
Böhler
T, Waiser J, Schütz M, Friedrich M, Schötschel R, Reinhold S, Schmouder
R, Budde K, Neumayer HH
FTY 720A mediates reduction of lymphocyte counts in human renal allograft
recipients by an apoptosis-independent mechanism
Transpl Int 13: 311 – 313 (2000)
Böhler
T, Waiser J, Hepburn H, Gaedeke J, Lehmann C, Hambach P, Budde K, Neumayer
HH
TNF-a and IL-1a induce apoptosis in subconfluent rat mesangial cells. Evidence
for the involvement of hydrogen peroxide and lipid perocidation as second
messengers.
Cytokine 12: 986 – 991 (2000)
Mai
I, Krüger H, Budde K, Johne A, Brockmöller J, Neumayer HH, Roots
I
Hazardous pharmacokinetic interaction of Saint John`s wort (Hypericum perforatum)
with the immunosuppressant cyclosporin
Int J Clin Pharm Ther 38: 500 – 502
Budde
K, Glander P, Bauer S, Braun K, Waiser J, Fritsche L, Mai I, Roots I, Neumayer
HH
Pharmacodynamic motitoring of mycophenolate mofetil
Clin Chem Lab Med 38 : 1213 – 1216 (2000)
Diekmann
F, Zart R, Thöne-Reineke C, Neumayer HH, Hocher B
Regulation of the renal endothelin system in the two-kidney, one-clip renal
hypertensive rat
J Cardiovasc Pharm 36 (Suppl. D): 191 – 194 (2000)
Fritsche
L, Jonitz G, Neumayer HH, Kunz R
Evidenzbasierte Medizin – Umsetzbarkeit und Umsetzung in die deutsche
Praxis
Dt Ärztebl 97 (Heft 12): A 766 – 767 (2000)
Fritsche
L, Vanrenterghem Y, Knut PN, Grinyo JM, Moreso F, Budde K, Kunz R, Meyerrose
B, Neumayer HH
Practice variations in the evaluation of adult Candidates for cadaveric kidney
transplantation
Transplantation 70: 1492 - 1497 (2000)
Schröter
K, Lindemann G, Fritsche L
TBase2 – a web-based Electronic Patient Record
Fundamenta informaticae 43: 343 – 353 (2000)
Fritsche
L, Schröter K, Lindemann G, Kunz R, Budde K, Neumayer HH
A Web-based electronic patient record system as a means for collection of
clinical data
Lecture Notes in Comput Sci Engl 1933: 198 – 205 (2000)
Fritsche
L, Nordal KP, Vanrenterghem Y, Grinyo JM, Moreso F, Budde K, Neumayer HH
Different diagnostic approaches to adult candidates for cadaveric kidney transplantation
in Europe
Transpl Int 13 (Suppl 1): 263 – 266
Hocher
B, Slowinski T, Stolze T, Pleschka A, Neumayer HH, Halle H
Association of maternal G protein b3 subunit 825T allele with low birthweight
Lancet 355: 1241 – 1242 (2000)
Hocher
B, Paul M
Transgenic animal models for the analysis of the renal endothelin system
Nephrol Dial Transplant 15: 935 – 937 (2000)
Hocher
B, Schwarz A, Fagan KA, Thöne-Reineke C, El-Hag K, Kusserow H, Elitok
S, Bauer C, Neumayer HH, Rodman DM, Theuring F
Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice
Am J Resp Cell Mol 23: 19 – 26 (2000)
Cho
JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn E, Riecken EO, Schuppan D.
An oral endothelin A receptor antagonist blocks collagen synthesis and deposition
in advanced liver fibrosis.
Gastroenterology 118: 1169 - 1178 (2000)
Pinto YM, Pinto-Sietsma SI, Philipp T, Engler S, Koßmehl P, Hocher B,
Marquardt H, Sethmann S, Lauster R, Merker HJ, Paul M
Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor
ß1 Attenuates Left Ventricular Fibrosis and Improves Survival Without
Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat
Hypertension 36: 747-754 (2000)
Filler G, Neuschulz I, Vollmer I, Amendt P, Hocher B
Intravenous glucose tolerance test in renal transplantation: tacrolimus versus
cylosporin.
Nephrol Dial Transplant 15(6):867-871.(2000)
Kaisers
U, Busch T, Wolf S, Lohbrunner H, Wilkens K, Hocher B, Boemke W
Inhaled endothelin A antagonist improves arterial oxygenation in experimental
acute lung injury
Intensive Care Med 26; 1334-1342 (2000)
Hocher
B, George I, Diekmann F, Zart R, Rebstock J, Neumayer HH, Bauer C
ETA Receptor Blockade induced Fibrosis of the clipped Kidney in Rats with
Renovascular Hypertension
J Hypertension 18: (12) 1807-1814 (2000)
Kunz
R, Khan KS, Neumayer HH
Observated studies and randomized trials
New Engl J Med 343 (16): 1194 – 1195, discussion 1196 – 1197
Kunz
R, Fritsche L
Evidenzbasierte Medizin – Von der Evidenz-Produktion zu ihrer Nutzung
Z Rheumatol 59 (1):38 – 40 (2000)
Kunz
R., Zink A
Ziele und Methoden klinischer Studien
Z Rheumatol 59: 41 - 44 (2000)
Kunz
R
Evidence-based Medicine im klinischen Alltag
Journal für Anästhesie und Intensivbehandlung 1: 105 - 106 (2000)
Donner-Banzhoff
N, Echterhoff HH, Hense HW, Kunz R, Sawicki P, ThürmannP, Jonitz G, Ollenschläger
G (Expertenkreis Hypertonie des Deutschen Leitlinien-Clearingverfahrens bei
der Ärztlichen Zentralstelle Qualitätssicherung)
Das Leitlinien-Clearingverfahren Hypertonie. Zusammenfassung und Empfehlungen
für eine nationale Hypertonieleitlinie für Deutschland
Z Ärztl Fortbild Qualitatssich 94: 341-349 (2000)
Kettner BI, Petersein J, Morgera S, Reisinger I, Munz DL
Passagere symptomatische Osteoporose unter Glukokortikoid-Therapie: Skelettszintigraphischer
und magnetresonanztomographischer Befund.
Nuklearmedizin 39: 121 – 145 (2000)
Felix
SB, Staudt A, Dorffel WV, Stangl V, Merkel K, Pohl M, Docke WD, Morgera S,
Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution
in dilated cardiomyopathy: three-month results from a randomized study
J Am Coll Cardiol 35 (6): 1590 – 1598 (2000)
Neumayer
HH
Akutes Nierenversagen – Präventivmaßnahmen
Journal für Anästhesie und Intensivbehandlung 1: 149 (2000)
Neumayer
HH, Waiser J, Budde K
Hypertension and renal transplantation.
Transplantationsmedizin (Suppl): 50 – 51 (2000)
Jacobi
J, Rockstroh J, John S, Schreiber M, Schlaich MP, Neumayer HH, Schmieder R
Prospective analysis of the value of 24-hour ambulatory blood pressure on
kidney transplantation
Transplantation 70 (5): 819 – 827
Midtvedt
K, Neumayer HH
Management strategies for posttransplant hypertension
Transplantation 70: 64 – 69 (2000)
Peters
H, Border NA, Noble NA
Tandem antifibrotic actions of L-arginine supplementation and low protein
diet during the repair phase of experimental glomerulonephritits
Kidney Int 57: 992 – 1001 (2000)
Peters
H, Border WA, Noble NA
Angiotensin II blockade and low protein diet produce additive therapeutic
effects on experimental glomerulonephritis
Kidney Int 57: 1493 – 1501 (2000)
Rothermund L, Pinto YM, Hocher B, Vetter R, Leggewie S, Kossmehl P, Orzechowski
HD, Kreutz R, Paul M
Cardiac endothelin system impairs left ventricular function in renin-dependent
hypertension via decreased sarcoplasmic reticulum Ca (2+) uptake
Circulation 102: 1582 – 1588 (2000)
Rothermund
L, Friebe A, Paul M, Koseling D, Kreutz R
Acute blood pressure effects of YC-1-induced activation of soluble guanylyl
cyclase in normotensive and hypertensive rats.
Br J Pharmacol 130 (2): 205 – 208, May 2 (2000)
Rothermund
L, Leggewie S, Schwarz A, Thone-Reinecke C, Cho JJ, Bauer C, Paul M, Neumayer
HH, Schuppan D, Hocher B
Regulation of the hepatic endothelin system in advanced biliary fibrosis in
rats
Clin Chem Lab Med 38: 507 – 512 (2000)
Rothermund
T, Cho JJ, Leggewie S, Schwarz A, Bauer C, Paul M, Neumayer HH, Hocher B
Activation of the hepatic endothelin-system in rats with biliary liver fibrosis
J Cardiovasc Pharm 36 (Suppl 1): 270 – 273 (2000)
Rothermund
L, Pinto Y, Hocher B , Vetter R, Leggewie S, Koßmehl P, Orzechowski
HD, Kreutz R, Paul M
Activation of the Cardiac Endothelin System Accounts for Heart Failure via
impaired cardiomyocyte Ca2+ handling in Angiotensin II-dependent Left Ventricular
Hypertrophy.
Circulation 102:1582-1588 (2000)
Kreutz
R, Kovacevic L, Schulz A, Rothermund L, Ketteler M, Paul M
Effect of high NaCl diet on spontaneous hypertension in a genetic rat model
with reduced nephron number.
J Hypertension 18: 777- 782 (2000)
Waiser
J, Schötschel R, Budde K, Neumayer HH
Reactivation of tuberculosis after conversion from azathioprine to mycophenolate
mofetil 16 years after renal transplantation
Am J Kidney Dis, 35: 1 – 6 (2000)
Waiser
J, Schreiber M, Budde K, Fritsche L, Böhler T, Hauser I, Neumayer HH
Age matching in renal transplantation
Nephrol Dial Transplant, 15: 696 – 700 (2000)
Waiser J, Schreiber M, Budde K, Böhler T, Kraus W, Hauser I, Riess R,
Neumayer HH
Prognostic value of the Banff classification
Transpl Int 13: 106 – 111 (2000)